New chiral N-(N,N-dialkylamino)sulfamoyl-1,2-diamine ligands for highly enantioselective transfer hydrogenation of ketones
摘要:
Chiral Ru(II) and Rh(III) complexes of N-(N,N-dialkylamino)sulfamoyl-1,2-diamine catalyze the transfer hydrogenation of various classes of aromatic ketones with high activity and excellent enantioselectivity. (C) 2002 Elsevier Science Ltd. All rights reserved.
New trinem antibiotics and inhibitors of beta-lactamases
申请人:LEK Pharmaceuticals d.d.
公开号:EP2135871A1
公开(公告)日:2009-12-23
The present invention relates to a compound of formula (I)
in particular compounds of formula (Ia),
the use of a therapeutically effective amount of one or more compounds of formula (I) or (Ia) as a broad-spectrum antibiotic and the use of a pharmaceutical composition comprising said compounds for the treatment of bacterial infections in humans or animals.
NEW TRINEM ANTIBIOTICS AND INHIBITORS OF BETA-LACTAMASES
申请人:Plantan Ivan
公开号:US20110166118A1
公开(公告)日:2011-07-07
The present invention relates to a compound of Formula (I) in particular compounds of formula (Ia), the use of a therapeutically effective amount of one or more compounds of formula (I) or (Ia) as a broad-spectrum antibiotic and the use of a pharmaceutical composition comprising said compounds for the treatment of bacterial infections in humans or animals.
The present disclosure relates to an improved process for the preparation of enantiomerically enriched alcohols of Formula (I),
from the corresponding ketone of Formula (II),
by asymmetric transfer hydrogenation, using a hydrogen donor, catalyzed by a ruthenium or rhodium complex of an optically active N-sulfamoyl-1,2-diamine. R is as defined herein.